ArticleCurrent oncology (Toronto, Ont.)2021

Body Composition as a Predictor of Toxicity and Prognosis in Patients with Diffuse Large B-Cell Lymphoma Receiving R-CHOP Immunochemotherapy.

Jiaxun Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.